TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA
Clinical trials for TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA explained in plain language.
Never miss a new study
Get alerted when new TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA trials appear
Sign up with your email to follow new studies for TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to free aplastic anemia patients from transfusions
Disease control Not yet recruitingThis study tests a combination of three drugs (cyclosporine, eltrombopag or hetrombopag, and romiplostim) in 43 adults newly diagnosed with severe aplastic anemia or a related condition requiring blood transfusions. The goal is to see if the treatment can restore blood cell produ…
Matched conditions: TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated May 26, 2026 08:31 UTC
-
New hope for aplastic anemia: drug combo aims to cut transfusion needs
Disease control Not yet recruitingThis study tests whether adding enarodustat to standard cyclosporine treatment helps people with newly diagnosed transfusion-dependent non-severe aplastic anemia. About 90 adults who cannot have a stem cell transplant will receive either the combo or cyclosporine alone. The goal …
Matched conditions: TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA
Phase: PHASE3 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New drug cocktail aims to free patients from blood transfusions
Disease control Not yet recruitingThis study tests a combination of three drugs (cyclosporine, eltrombopag/hetrombopag, and romiplostim) in 43 adults newly diagnosed with severe aplastic anemia or a related condition that requires blood transfusions. The goal is to see if the combo can help the bone marrow produc…
Matched conditions: TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New combo therapy aims to free anemia patients from blood transfusions
Disease control Not yet recruitingThis study tests whether adding enarodustat to the standard drug cyclosporine works better than cyclosporine alone for adults with a type of anemia that requires regular blood transfusions. The goal is to see if the combination can improve blood counts and reduce the need for tra…
Matched conditions: TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA
Phase: PHASE3 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated May 22, 2026 13:50 UTC